Filing Flows › Celularity (CELU) › Q1 2026
Celularity (CELU) Q1 2026 earnings results (first quarter 2026)
10-Q filed Sep 29, 2026
Celularity (CELU) reported revenue of $3.8M for the first quarter 2026 (Q1 2026), -66% from a year earlier and -6% from the quarter before. Operating margin was -263.5%, net earnings $874K (22.7% of revenue).
Celularity, Q1 2026: revenue $3.8M (-66% year over year), operating margin -263.5%, net earnings $874K, operating cash flow $1.4M. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.8M | -6% | -66% |
| Operating profit | −$10.1M | — | — |
| Net earnings | $874K | — | — |
| Operating cash flow | $1.4M | — | — |
What changed
Revenue was $3.8M in Q1 2026, down 66% year over year and down 6% from the previous quarter. License Royalty and Other was the largest line at 45% of revenue. Product lost $8.2M year over year (down 90%), 108% of the total change.
Operating costs exceeded revenue by $10.1M, an operating margin of -263.5%. Total costs fell 36% while revenue fell 66%. Net earnings were $874K. The effective tax rate was 0.0%. Non-operating items added $11.0M, 1259% of pre-tax earnings, so the bottom line overstates operating performance.
Operating cash flow was $1.4M, 166% of net earnings. Non-cash charges added back $1.6M of depreciation and amortization and $1.2M of share-based compensation. Working capital and other items used $2.3M.
Questions
What was Celularity's revenue in the first quarter 2026?
Celularity (CELU) reported revenue of $3.8M for the first quarter 2026 (Q1 2026), -66% from a year earlier and -6% from the quarter before.
Was Celularity profitable in the first quarter 2026?
Operating loss was $10.1M (-263.5% of revenue) and net earnings $874K.
Source: Celularity 10-Q on SEC EDGAR.